Posted inCardiology news
Large Clonal Hematopoiesis Clones Drive Myocardial Infarction Risk in People With HIV
Data from the REPRIEVE trial indicates that while general clonal hematopoiesis is common in people with HIV, only large clones (VAF ≥10%) significantly elevate the risk for myocardial infarction and revascularization, independent of traditional risk factors and statin therapy.